What is monkeypox vaccine and what is it used for?
Monkeypox vaccine is a vaccine used to protect against smallpox in adults. It contains an attenuated form of the damalitis virus called "modified Ankara-type damalitis virus" that is related to the smallpox virus. Smallpox was officially declared eradicated in 1980, with the last known case of the disease being recorded in 1977. This vaccine will be used in cases where it is considered necessary to protect against smallpox in accordance with official recommendations; the monkeypox vaccine may also be used to protect adults against monkeypox and disease caused by the Dalmatian virus.
How is the monkeypox vaccine used?
The monkeypox vaccine is administered by subcutaneous injection, preferably in the upper arm. Persons who have not previously been vaccinated against smallpox, monkeypox or disease caused by the damalitis virus should receive two 0,5 ml doses, with the second dose administered at least 28 days after the first. Where necessary, the administration of a booster dose to persons previously vaccinated should be administered as a single dose of 0,5 ml. Persons with a compromised immune system (the body's natural defences) who need to receive a booster dose should receive two doses, the second dose being administered at least 28 days after the first. The vaccine is only administered on prescription. For more information on the use of the monkeypox vaccine, consult the package leaflet or contact your doctor or pharmacist.
How does the monkeypox vaccine work?
Vaccines work by preparing the body to defend itself against a disease. When the vaccine is given to a person, the immune system recognises the virus in the vaccine as a "foreign" body and produces antibodies against it. When the person is re-exposed to similar viruses, the monkeypox vaccine (live modified Ankara-type tamalitis virus) these antibodies, in combination with other components of the immune system, will be able to kill the viruses and help protect against the disease. the monkeypox vaccine prepares the body to defend itself against infection by the smallpox, monkeypox and damalitis viruses. It contains an attenuated form of the Dalmatian virus called 'modified Ankara-type Dalmatian virus', a virus that is closely related to the smallpox and monkeypox viruses, but is not pathogenic to humans and cannot replicate in human cells. Due to the similarity between the virus of the monkeypox vaccine and these viruses, antibodies produced against this virus are expected to provide protection against monkeypox, smallpox and damalitis virus.
What are the benefits of the monkeypox vaccine according to the studies?
The studies showed that the monkeypox vaccine is effective in triggering the production of antibodies at a level sufficient to provide protection against smallpox. Five main studies were conducted. More than 2,000 adults, including patients with HIV and atopic dermatitis (a skin condition with accompanying itching caused by an overactive immune system) and people who had previously been vaccinated against smallpox, participated in the studies. Two of the studies specifically examined the efficacy of the monkeypox vaccine as a booster dose of vaccine. A subsequent study involving 433 previously unvaccinated individuals found that the level of protective antibodies after vaccination with the monkeypox vaccine was at least as high as that provided by a conventional smallpox vaccine. The duration of protection is not yet known. Data from several animal studies have demonstrated protection against monkeypox in non-human primates which have been vaccinated with the monkeypox vaccine and subsequently exposed to monkeypox virus. The monkeypox vaccine is also expected to provide protection against disease caused by the damalitis virus, since the vaccine is based on a modified version of the damalitis virus.
What are the risks associated with the monkeypox vaccine?
The most common side effects of the monkeypox vaccine (which may occur in more than 1 in 10 people) are headache, nausea, myalgia (muscle pain), fatigue and injection site reactions (pain, redness, swelling, hardening and itching).
The monkeypox vaccine should not be administered to patients who are hypersensitive (allergic) to the active substance or to traces of any substance in the vaccine, such as horn proteins, benzonase and gentamicin. For a full list of side effects and restrictions, consult the package leaflet.
(AF)
Contents of this article including associated images are owned by PIO
Views & opinions expressed are those of the author and/or PIO
Source